NSE: INSECTICID | BSE: 532851

Strong Performer

Download real time

960.45 -22.80 (-2.32%)

77.03% Gain from 52W Low

116.4K NSE+BSE Volume

NSE 26 Jun, 2025 3:31 PM (IST)

2,794.7

Market Cap

Above industry Median

0.8

Beta 1Year

Very Low volatility

Insecticides (India) Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for INSECTICID, BSE:532851 Insecticides (India) Ltd.

Insecticides (India) Ltd.

31 May 2022

960.45

-2.32%

INSECTICIDES (INDIA)

Hold: Insecticides (India) Ltd.

Prabhudas Lilladhar

Axis Direct released a Buy report for Insecticides (India) Ltd. with a price target of 955.0 on 12 Jun, 2025.

Insecticides (India) Ltd.

13 Feb 2022

960.45

-2.32%

INSECTICIDES (INDIA)

Hold: Insecticides (India) Ltd.

Target

Prabhudas Lilladhar

commencement of new capacities and 4) backward integration projects. In the current scenario of buoyant stock markets, steep discount at which INST trades vis--vis its peers has only expanded. Even a marginal contraction in discount can lead to rerating of multiples. Maintain HOLD' with TP of Rs680 (Unchanged) based on 10x FY24E EPS. Decent show in challenging times: INST reported revenue/EBITDA/PAT growth of 5%/23%/36% YoY better than our estimates. B2C/ B2B/ exports contributed to...

Insecticides (India) Ltd. is trading above all available SMAs

Insecticides (India) Ltd.

21 Jun 2021

960.45

-2.32%

Q4FY21 Result Update - New launches to drive growth - Downgrade to 'ACCUMULATE'

Insecticides (India) Ltd.

Recommendation Target

Prabhudas Lilladhar

We increase our EBITDA/PAT estimates by 8%/13% for FY22E and 3%/5% for FY23E to factor in higher business growth from new launches and better margin profile of inlicensing molecules. We roll over to FY23 earnings, increase the target multiple on the stock from 9x to 11x. Due to recent run-up in stock price, we downgrade the stock to ACCUMULATE (from Buy) with revise target price of Rs 817 (Previous 506) based on 11x FY23 EPS of Rs 74.3. In the current scenario of buoyant stock markets, the steep discount at...

Insecticides (India) Ltd. has gained 25.50% in the last 1 Month

Insecticides (India) Ltd.

05 Mar 2021

960.45

-2.32%

Monthly Update - Fertiliser sales takes a breather in February

Buy: Insecticides (India) Ltd.

Prabhudas Lilladhar

We maintain reduce rating (TP- Rs 676) on CRIN due to capacity constraints in NPK and likely headwinds on the raw material side starting 4Q. We are positive on Urea companies given healthy volumes and significantly lower...

Axis Direct released a Buy report for Insecticides (India) Ltd. with a price target of 955.0 on 12 Jun, 2025.

Insecticides (India) Ltd.

09 Feb 2021

960.45

-2.32%

Q3FY21 Result Update - Another disappointing quarter - BUY

Buy: Insecticides (India) Ltd.

Target

Prabhudas Lilladhar

INST reported yet another quarter with subdued performance. Despite healthy topline growth of 14%, gross margins contracted by sharp 490 bps YoY (regardless of a weak base) due to inventory liquidation of Nuvan (banned from 1st Jan'21). The management is hopeful of business turnaround in the ensuing quarters driven by 1) its pipeline of new launches 2) commencement of new capacities and 3) backward integration projects. We increase our topline estimates by 5% for each FY21-23 but reduce our EBITDA/APAT...

Insecticides (India).. has an average target of 952.00 from 2 brokers.

Insecticides (India) Ltd.

04 Dec 2020

960.45

-2.32%

Monthly Update - Placement growth tapers down in November

Buy: Insecticides (India) Ltd.

Prabhudas Lilladhar

Insecticides (India) Ltd. is trading above all available SMAs

Insecticides (India) Ltd.

10 Nov 2020

960.45

-2.32%

Q2FY21 Result Update - An uneventful quarter - BUY

Buy: Insecticides (India) Ltd.

Target

Prabhudas Lilladhar

INST reported yet another quarter with subdued performance. Topline decline of 9% (PLe 8%) was due to adverse weather situation across various states leading to lower sprays and higher sales return. INST did a commendable job with ~28% decline in receivables due to focus on cash sales and quick collections. The management is hopeful of recovery 2H onwards driven by its pipeline of new launches and commencement of new capacities. We lower our EBITDA/APAT estimates by 2%/3% for each of FY22E and FY23E to factor...

Insecticides (India) Ltd. has gained 25.50% in the last 1 Month

Insecticides (India) Ltd.

17 Aug 2020

960.45

-2.32%

Q1FY21 Result Update - Disappointing numbers - BUY

Buy: Insecticides (India) Ltd.

Target

Prabhudas Lilladhar

Insecticides India's sharp contraction of 690 bps in gross margin was driven by (a) raw material cost inflation (b) Scarcity in raw material supply of Maharatna products that deteriorated sales mix in favour of generic products (at 60% v/s 55% YoY) and (c) heightened competition in Nuvaan (to be banned on 31.12.20). The management expects margins to improve in Q2 as Maharatna sales are expected to pick up. FY21 looks like a challenging year for INST due to (a) significant reduction in sale of Thimet and Nuvan (FY20~Rs 1.7 bn; FY21E Rs 450 mn) (b) INST as well as its suppliers face pressure due to labour unavailability and logistics issues and (c) Challenges in the...

Number of FII/FPI investors decreased from 62 to 50 in Mar 2025 qtr

Insecticides (India) Ltd.

31 May 2019

960.45

-2.32%

Q4FY19 Result Update

Buy: Insecticides (India) Ltd.

Prabhudas Lilladhar

INST's outperformance vis--vis domestic industry continued in Q4FY19 with Change in Estimates | Target | Reco topline/EBITDA/PBT growth of 18%/55%/62% YoY, driven by new launches. Led by its strong product pipeline, this performance is expected to sustain...

Insecticides (India) Ltd. is trading above all available SMAs

Insecticides (India) Ltd.

13 Nov 2018

960.45

-2.32%

Insecticides India (2QFY19): Flurry of new products. Maintain BUY

Buy: Insecticides (India) Ltd.

Target

HDFC Securities

Maintain BUY with a TP of Rs 960/sh (17x Sept-20 EPS). Insecticides Indias (INST) reported a healthy 2QFY19 performance amidst rupee depreciation and higher input costs (technicals). Sales/EBITDA/PAT grew by 10.0/24.4/18.9% YoY to Rs 4.5bn/Rs 692mn/Rs 430 mn respectively.

Insecticides (India) Ltd. has gained 34.81% in the last 6 Months

Is Insecticides (India) Ltd. worth buying?

71 Votes:

Buy 77.46%

Sell 15.49%

Hold 7.04%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Not Rated SEE REPORTS >

pdf